Literature DB >> 17015726

Transitional B cell fate is associated with developmental stage-specific regulation of diacylglycerol and calcium signaling upon B cell receptor engagement.

Kristen L Hoek1, Pierre Antony, John Lowe, Nicholas Shinners, Bhaskarjyoti Sarmah, Susan R Wente, Demin Wang, Rachel M Gerstein, Wasif N Khan.   

Abstract

Functional peripheral mature follicular B (FoB) lymphocytes are thought to develop from immature transitional cells in a BCR-dependent manner. We have previously shown that BCR cross-linking in vitro results in death of early transitional (T1) B cells, whereas late transitional (T2) B cells survive and display phenotypic characteristics of mature FoB cells. We now demonstrate that diacylglycerol (DAG), a lipid second messenger implicated in cell survival and differentiation, is produced preferentially in T2 compared with T1 B cells upon BCR cross-linking. Consistently, inositol 1,4,5-triphosphate is also produced preferentially in T2 compared with T1 B cells. Unexpectedly, the initial calcium peak appears similar in both T1 and T2 B cells, whereas sustained calcium levels are higher in T1 B cells. Pretreatment with 2-aminoethoxydiphenylborate, an inhibitor of inositol 1,4,5-triphosphate receptor-mediated calcium release, and verapamil, an inhibitor of L-type calcium channels, preferentially affects T1 B cells, suggesting that distinct mechanisms regulate calcium mobilization in each of the two transitional B cell subsets. Finally, BCR-mediated DAG production is dependent upon Bruton's tyrosine kinase and phospholipase C-gamma2, enzymes required for the development of FoB from T2 B cells. These results suggest that calcium signaling in the absence of DAG-mediated signals may lead to T1 B cell tolerance, whereas the combined action of DAG and calcium signaling is necessary for survival and differentiation of T2 into mature FoB lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17015726     DOI: 10.4049/jimmunol.177.8.5405

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Subcellular localization of Grb2 by the adaptor protein Dok-3 restricts the intensity of Ca2+ signaling in B cells.

Authors:  Björn Stork; Konstantin Neumann; Ingo Goldbeck; Sebastian Alers; Thilo Kähne; Michael Naumann; Michael Engelke; Jürgen Wienands
Journal:  EMBO J       Date:  2007-02-08       Impact factor: 11.598

2.  Developmentally regulated expression of MEF2C limits the response to BCR engagement in transitional B cells.

Authors:  Sarah F Andrews; Xuezhi Dai; Byoung Y Ryu; Tod Gulick; Bindu Ramachandran; David J Rawlings
Journal:  Eur J Immunol       Date:  2012-05       Impact factor: 5.532

3.  Arachidonic acid-induced activation of large-conductance potassium channels and membrane hyperpolarization in mouse B cells.

Authors:  Haifeng Zheng; Joo Hyun Nam; Yen Hoang Nguen; Tong Mook Kang; Tae Jin Kim; Yung E Earm; Sung Joon Kim
Journal:  Pflugers Arch       Date:  2008-01-24       Impact factor: 3.657

4.  B cell receptor-mediated sustained c-Rel activation facilitates late transitional B cell survival through control of B cell activating factor receptor and NF-kappaB2.

Authors:  Iris Castro; Jacqueline A Wright; Bazarragchaa Damdinsuren; Kristen L Hoek; Gianluca Carlesso; Nicholas P Shinners; Rachel M Gerstein; Robert T Woodland; Ranjan Sen; Wasif N Khan
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

5.  Signalling of the BCR is regulated by a lipid rafts-localised transcription factor, Bright.

Authors:  Christian Schmidt; Dongkyoon Kim; Gregory C Ippolito; Hassan R Naqvi; Loren Probst; Shawn Mathur; German Rosas-Acosta; Van G Wilson; Athenia L Oldham; Martin Poenie; Carol F Webb; Philip W Tucker
Journal:  EMBO J       Date:  2009-02-12       Impact factor: 11.598

Review 6.  Calcium Signaling: From Normal B Cell Development to Tolerance Breakdown and Autoimmunity.

Authors:  Patrice Hemon; Yves Renaudineau; Marjolaine Debant; Nelig Le Goux; Sreya Mukherjee; Wesley Brooks; Olivier Mignen
Journal:  Clin Rev Allergy Immunol       Date:  2017-10       Impact factor: 8.667

7.  Transitional B cells exhibit a B cell receptor-specific nuclear defect in gene transcription.

Authors:  Sarah F Andrews; David J Rawlings
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

Review 8.  B-lymphocyte tolerance and effector function in immunity and autoimmunity.

Authors:  Wasif N Khan; Jacqueline A Wright; Eden Kleiman; Justin C Boucher; Iris Castro; Emily S Clark
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

9.  B-cell reconstitution and BAFF after alemtuzumab (Campath-1H) treatment of multiple sclerosis.

Authors:  Sara A J Thompson; Joanne L Jones; Amanda L Cox; D Alastair S Compston; Alasdair J Coles
Journal:  J Clin Immunol       Date:  2009-09-10       Impact factor: 8.317

10.  Developmental acquisition of the Lyn-CD22-SHP-1 inhibitory pathway promotes B cell tolerance.

Authors:  Andrew J Gross; Julia R Lyandres; Anil K Panigrahi; Eline T Luning Prak; Anthony L DeFranco
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.